← back to search

Daniel F. Levey

Yale University · US
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Genetic Associations and Epidemiology, Epigenetics and DNA Methylation, Tryptophan and brain disorders, and Substance Abuse Treatment and Outcomes.
h-index
41
citations
8,027
works
174
NIH funding
primary concept
Medicine
email

Recent publications

Single-cell transcriptomic and chromatin dynamics of the human brain in PTSD
Nature 2025cited by 35position: middledoi
Robust inference and widespread genetic correlates from a large-scale genetic association study of human personality
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 12position: middledoi
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program
Science 2024cited by 339position: middledoi
Multi-ancestry genome-wide association study of major depression aids locus discovery, fine mapping, gene prioritization and causal inference
Nature Genetics 2024cited by 165position: middledoi
A genome-wide investigation into the underlying genetic architecture of personality traits and overlap with psychopathology
Nature Human Behaviour 2024cited by 56position: lastdoi
Whole-exome sequencing in UK Biobank reveals rare genetic architecture for depression
Nature Communications 2024cited by 30position: middledoi
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood–brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas
Neuro-Oncology 2024cited by 28position: middledoi
Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling
medRxiv 2024cited by 24position: middledoi
Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders
Psychiatry Research 2024cited by 17position: middledoi
Genetic influences and causal pathways shared between cannabis use disorder and other substance use traits
Molecular Psychiatry 2024cited by 15position: middledoi
Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction
Nature Communications 2024cited by 12position: middledoi
Alcohol use and risk of dementia in diverse populations
medRxiv 2024cited by 2position: middledoi
Opioid use disorder and brain health: observational and genetic associations
medRxiv 2024cited by 0position: middledoi
Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses
Nature Medicine 2023cited by 296position: middledoi
Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals
Nature Medicine 2023cited by 173position: middledoi
Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications
Nature Genetics 2023cited by 113position: firstdoi
Modeling the longitudinal changes of ancestry diversity in the Million Veteran Program
Human Genomics 2023cited by 24position: middledoi
Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci
Molecular Psychiatry 2022cited by 133position: middledoi
Exploring the genetic overlap between twelve psychiatric disorders
Nature Genetics 2022cited by 99position: middledoi
Genetic variants associated with psychiatric disorders are enriched at epigenetically active sites in lymphoid cells
Nature Communications 2022cited by 43position: middledoi
Integrating human brain proteomes with genome-wide association data implicates novel proteins in post-traumatic stress disorder
Molecular Psychiatry 2022cited by 38position: middledoi
Identification of 64 new risk loci for major depression, refinement of the genetic architecture and risk prediction of recurrence and comorbidities
medRxiv 2022cited by 12position: middledoi
Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions
Nature Neuroscience 2021cited by 429position: firstdoi
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors
Biological Psychiatry 2021cited by 242position: middledoi
Genome-wide association analyses of post-traumatic stress disorder and its symptom subdomains in the Million Veteran Program
Nature Genetics 2021cited by 241position: middledoi
Genetic contributions to anxiety disorders: where we are and where we are heading
Psychological Medicine 2021cited by 68position: middledoi
Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits
Nature Neuroscience 2020cited by 402position: middledoi
International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci
Nature Communications 2019cited by 677position: middledoi
Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in >165,000 US veterans
Nature Neuroscience 2019cited by 212position: middledoi
Genome-wide Association Study of Maximum Habitual Alcohol Intake in >140,000 U.S. European and African American Veterans Yields Novel Risk Loci
Biological Psychiatry 2019cited by 101position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Joel Gelernter · Yale University16 papers (2014–2024)Renato Polimanti · Yale University9 papers (2019–2024)Hang Zhou · Beijing Union University5 papers (2020–2024)Henry R. Kranzler · University of Pennsylvania5 papers (2014–2024)Gita A. Pathak · Genomic Health (United States)5 papers (2021–2024)Kelly Harrington · Boston University4 papers (2019–2023)Mihaela Aslan · Yale University4 papers (2019–2023)Frank R. Wendt · Connecticut Health Foundation4 papers (2021–2023)Marco Galimberti · University of Fribourg3 papers (2022–2024)Rachel L. Kember · Penn Center for AIDS Research3 papers (2020–2024)Rachel Quaden · VA Boston Healthcare System3 papers (2019–2021)John Concato · United States Food and Drug Administration3 papers (2019–2021) · 2 papers (2024–2024)Zhongshan Cheng · Yale University2 papers (2020–2021)Neha Jain · Indiana University School of Medicine2 papers (2012–2014)Emma C. Johnson · North Carolina State University2 papers (2020–2022)J. Michael Gaziano · VA Boston Healthcare System2 papers (2019–2024) · 2 papers (2023–2024)Ditte Demontis · Broad Institute2 papers (2022–2024)Arpana Agrawal · University of Oslo2 papers (2020–2022)